The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial

被引:44
|
作者
Hermans, Job [1 ]
Bierma-Zeinstra, Sita M. A. [1 ,2 ]
Bos, Pieter K. [1 ]
Niesten, Dieu Donne [3 ]
Verhaar, Jan A. N. [1 ]
Reijman, Max [1 ]
机构
[1] Erasmus Univ, Dept Orthopaed Surg, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Dept Gen Practice, Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands
[3] Reinier de Graaf Hosp, Dept Orthopaed Surg, POB 5011, NL-2600 GA Delft, Netherlands
关键词
Knee osteoarthritis; Hyaluronic acid; Effectiveness; Randomised controlled trial; Working age; TASK-FORCE; MANAGEMENT; EFFICACY; SOCIETY; BURDEN; COSTS; RISK; HIP;
D O I
10.1186/s12891-019-2546-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundHigh molecular weight (HMW) hyaluronic acid (HA) is a treatment option for knee osteoarthritis (OA). The efficacy of HMW-HA in knee OA is investigated extensively, but the effectiveness in patients in the working age is unknown. Nevertheless, the number knee OA patients in the working age is increasing. Surgical treatment options are less eligible in these patients and productivity losses are high. In this study the effectiveness of intra-articular HMW-HA added to regular non-surgical usual care in everyday clinical practice (UC) compared to UC over 52weeks in symptomatic knee OA patients in the working age was investigated.MethodsIn this open labelled randomized controlled trial, subjects aged between 18 and 65years with symptomatic knee OA (Kellgren and Lawrence I-III) were enrolled and randomized to UC+3 weekly injections with HMW-HA (intervention) or UC only (control). The primary outcome was the between group difference in responders to therapy according to OMERACT-OARSI criteria after 52weeks. These criteria include the domains pain, knee related function and patient's global assessment (PGA). Function was evaluated with the KOOS questionnaire. Pain was assessed with the Numeric Rating Scale. Secondary outcome comprised the between group difference on the individual responder domains, as analysed with a random effects model. Odds Ratios (OR) were calculated by logistic regression analysis. Sensitivity analyses were performed.ResultsIn total, 156 subjects were included (intervention group 77, control group 79). Subjects in the intervention group (HMW-HA+UC) were more often responder compared to the controls (UC). Depending on whether pain during rest or pain during activity was included in the responder domains, 57.1% versus 34.2% (p=0.006) and 54.5% versus 34.2% (p=0.015) was responder to therapy respectively. The results of the secondary outcome analyses show that scores on individual responder domains over all follow-up moments were statistically significant in favour of the intervention group in the domains pain during rest ( 0.8, 95%CI 0.2; 1.4, p=0.010), knee related function ( -6.8, 95%CI -11.9; -1.7, p=0.010) and PGA ( -0.7, 95%CI -0.9; -0.4, p<0.0001).ConclusionsIntra-articular HMW-HA added to usual care is effective for knee OA in patients in the working age.Trial registrationwww.trialregister.nl, NTR1651, registered 2009-3-3.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial
    Job Hermans
    Sita M. A. Bierma-Zeinstra
    Pieter K. Bos
    Dieu Donne Niesten
    Jan A. N. Verhaar
    Max Reijman
    BMC Musculoskeletal Disorders, 20
  • [2] Cost-Utility Analysis of High Molecular Weight Hyaluronic Acid for Knee Osteoarthritis in Everyday Clinical Care in Patients at a Working Age: An Economic Evaluation of a Randomized Clinical Trial
    Hermans, Job
    Reijman, Max
    Goossens, Lucas M. A.
    Verburg, Hennie
    Bierma-Zeinstra, Sita M. A.
    Koopmanschap, Marc A.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (01) : 89 - 97
  • [3] EVALUATION OF EFFECTIVENESS OF HIGH MOLECULAR WEIGHT HYALURONIC ACID IN POST-TRAUMATIC OSTEOARTHRITIS OF THE KNEE JOINT
    Nesterenko, V. A.
    Bialik, B. E.
    Makarov, M. M.
    Karateev, K. A.
    Bialik, B. V.
    Stadnik, S. V.
    Makarov, M. S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S579 - S579
  • [4] Comparison of the Efficacy of Two High-Molecular-Weight Hyaluronic Acid Products for Patients With Knee Osteoarthritis
    oNuMA, HiRoyuki
    suGiHARA, TosHiHiRo
    ORTHOPEDICS, 2022, 45 (01) : 13 - +
  • [5] A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis
    Berenbaum, Francis
    Grifka, Joachim
    Cazzaniga, Sara
    D'Amato, Massimo
    Giacovelli, Giampaolo
    Chevalier, Xavier
    Rannou, Francois
    Rovati, Lucio C.
    Maheu, Emmanuel
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (09) : 1454 - 1460
  • [6] Baropodometric and stabilometric analysis in patients affected by knee osteoarthritis after treatment with high molecular weight hyaluronic acid
    Carbone, A.
    Ammendolia, A.
    d'Esposito, O.
    Spaccaferro, D.
    Indino, A.
    Elia, R. Longo
    Guerrieri, V.
    Iocco, M.
    43RD CONGRESSO NAZIONALE SIMFER, 2015, 2016, : 12 - 13
  • [7] Hyaluronic acid in knee osteoarthritis - effectiveness and efficiency
    Paul Kuijer
    TBV – Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, 2021, 29 (3): : 46 - 46
  • [8] THE EFFECTIVENESS OF PLATELET RICH PLASMA, HYALURONIC ACID AND PEPTIDE INJECTIONS IN KNEE OSTEOARTHRITIS TREATMENT: A PROSPECTIVE RANDOMISED CONTROLLED STUDY
    Kesiktas, N.
    Dernek, B.
    Albayrak, H.
    Yildiz, M.
    Aydin, T.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S538 - S538
  • [9] Polyacrylamide gel versus hyaluronic acid for the treatment of knee osteoarthritis: a randomised controlled study
    Bliddal, H.
    Beier, J.
    Hartkopp, A.
    Conaghan, P. G.
    Henriksen, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 1729 - 1735
  • [10] HEALTH ECONOMICS EVALUATION OF A HIGH AND LOW MOLECULAR WEIGHT HYALURONIC ACID FORMULATION IN PATIENTS WITH KNEE OSTEOARTHRITIS. ANALYSES FROM A RANDOMIZED CLINICAL TRIAL
    Bruyere, O.
    Reginster, J-Y
    Honvo, G.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S50 - S50